Expression of recombinant antibodies

Frontiers in Immunology

Volumn 4, Issue JUL, 2013, Pages

  Frenzel, André ^a   Hust, Michael ^a   Schirrmann, Thomas ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Fungi; Insect cells; Mammalian cell; Procaryotes; Recombinant antibody; Transgenic organisms; Yeast

Indexed keywords

ATRAZINE; BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; CD18 ANTIGEN; CD2 ANTIGEN; CD200 ANTIGEN; CD22 ANTIGEN; CYTOKERATIN 8; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GLYCOPROTEIN; GLYCOPROTEIN GP 41; LYSOZYME; MUCIN 1; PHOSPHORYLCHOLINE; RAS PROTEIN; RECOMBINANT ANTIBODY; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SEPRASE; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANTIBODY PRODUCTION; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INSECT CELL; MAMMAL CELL; NONHUMAN; PROTEIN EXPRESSION; PROTOZOON; REVIEW; TRANSGENIC ORGANISM; YEAST;

EID: 84883702935     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00217     Document Type: Review

References (306)

1. Colwill K, Renewable Protein Binder Working Group, Gräslund S. A roadmap to generate renewable protein binders to the human proteome. Nat Methods (2011) 8:551-8. doi:10.1038/nmeth.1607
2. Mehan MR, OstroffR, Wilcox SK, Steele F, Schneider D, Jarvis TC, et al. Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics. Adv Exp Med Biol (2013) 735:283-300.
3. Foudeh AM, Fatanat Didar T, Veres T, Tabrizian M. Microfluidic designs and techniques using lab-on-a-chip devices for pathogen detection for point-of-care diagnostics. Lab Chip (2012) 12:3249-66. doi:10.1039/c2lc40630f
4. Uttamchandani M, Neo JL, Ong BNZ, Moochhala S. Applications of microarrays in pathogen detection and biodefence. Trends Biotechnol (2009) 27:53-61. doi:10.1016/j.tibtech.2008.09.004
5. Van Breedam W, Costers S, Vanhee M, Gagnon CA, Rodríguez-Gómez IM, Geldhof M, et al. Porcine reproductive and respiratory syndrome virus (PRRSV)- specific mAbs: supporting diagnostics and providing new insights into the antigenic properties of the virus. Vet Immunol Immunopathol (2011) 141:246-57. doi:10.1016/j.vetimm.2011.03.008
6. Van Hoeven KH, Dale C, Foster P, Body B. Comparison of three enzyme-linked immunosorbent assays for detection of immunoglobulin g antibodies to tetanus toxoid with reference standards and the impact on clinical practice. Clin Vaccine Immunol (2008) 15:1751-4. doi:10.1128/CVI.00254-08
7. Zasada AA, Rastawicki W, Smietanska K, Rokosz N, Jagielski M. Comparison of seven commercial enzyme-linked immunosorbent assays for the detection of anti-diphtheria toxin antibodies. Eur J Clin Microbiol Infect Dis (2013) 32:891-7. doi:10.1007/s10096-013-1823-y
8. Dübel S editor. Handbook of Therapeutic Antibodies. Weinheim: Wiley-VCH (2008). doi:10.1002/9783527619740
9. Reichert JM. Which are the antibodies to watch in 2013?. MAbs (2013) 5:1-4. doi:10.4161/mabs.22976
10. Eisenberg SA. Biologic therapy. J Infus Nurs (2012) 35:301-13. doi:10.1097/NAN.0b013e31826579aa
11. Dimitrov DS. Therapeutic proteins. In: Voynov V, Caravella JA editors. Therapeutic Proteins, Methods in Molecular Biology. Clifton, NJ: Humana Press (2012). p. 1-26.
12. Wilde H, Thipkong P, Sitprija V, Chaiyabutr N. Heterologous antisera and antivenins are essential biologicals: perspectives on a worldwide crisis. Ann Intern Med (1996) 125:233-6. doi:10.7326/0003-4819-125-3-199608010-00012
13. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (1975) 256:495-7. doi:10.1038/256495a0
14. Reichert JM. Antibody-based therapeutics to watch in 2011. MAbs (2011) 3:76-99. doi:10.4161/mabs.3.1.13895
15. Reichert JM. Antibodies to watch in 2010. MAbs (2010) 2:84-100. doi:10.4161/mabs.2.1.10677
16. Nemazee DA, Bürki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature (1989) 337:562-6. doi:10.1038/337562a0
17. Taylor LD, Carmack CE, Schramm SR, Mashayekh R, Higgins KM, Kuo CC, et al. A transgenic mouse that expresses a diversity of human sequence heavy and light chain immunoglobulins. Nucleic Acids Res (1992) 20:6287-95. doi:10.1093/nar/20.23.6287
18. Breitling F, Dübel S, Seehaus T, Klewinghaus I, Little M. A surface expression vector for antibody screening. Gene (1991) 104:147-53. doi:10.1016/0378-1119(91) 90244-6
19. Edwards BM, He M. Evolution of antibodies in vitro by ribosome display. Methods Mol Biol (2012) 907:281-92.
20. Hoogenboom HR. Selecting and screening recombinant antibody libraries. Nat Biotechnol (2005) 23:1105-16. doi:10.1038/nbt1126
21. Schirrmann T, Meyer T, Schütte M, Frenzel A, Hust M. Phage display for the generation of antibodies for proteome research, diagnostics and therapy. Molecules (2011) 16:412-26. doi:10.3390/molecules16010412
22. Thom G, Groves M. Ribosome display. Methods Mol Biol (2012) 901:101-16. doi:10.1007/978-1-61779-931-0_6
23. Edelman GM. Antibody structure and molecular immunology. Science (1973) 180:830-40. doi:10.1126/science.180.4088.830
24. Bird RE, Hardman KD, Jacobson JW, Johnson S, Kaufman BM, Lee SM, et al. Single-chain antigen-binding proteins. Science (1988) 242:423-6. doi:10.1126/science.3140379
25. Schmiedl A, Breitling F, Winter CH, Queitsch I, Dübel S. Effects of unpaired cysteines on yield, solubility and activity of different recombinant antibody constructs expressed in E. coli. J Immunol Methods (2000) 242:101-14. doi:10.1016/S0022-1759(00)00243-X
26. Hust M, Jostock T, Menzel C, Voedisch B, Mohr A, Brenneis M, et al. Single chain Fab (scFab) fragment. BMC Biotechnol (2007) 7:14. doi:10.1186/1472-6750-7-14
27. Hudson PJ, Kortt AA. High avidity scFv multimers; diabodies and triabodies. J Immunol Methods (1999) 231:177-89. doi:10.1016/S0022-1759(99)00157-X
28. Hu S, Shively L, Raubitschek A, Sherman M, Williams LE, Wong JY, et al. Minibody: a novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Cancer Res (1996) 56:3055-61.
29. Kipriyanov SM, Breitling F, Little M, Dübel S. Single-chain antibody streptavidin fusions: tetrameric bifunctional scFv-complexes with biotin binding activity and enhanced affinity to antigen. Hum Antibodies Hybridomas (1995) 6:93-101.
30. Kujau MJ, Hoischen C, Riesenberg D, Gumpert J. Expression and secretion of functional miniantibodies McPC603scFvDhlx in cell-wall-less L-form strains of Proteus mirabilis and Escherichia coli: a comparison of the synthesis capacities of L-form strains with an E. coli producer strain. Appl Microbiol Biotechnol (1998) 49:51-8. doi:10.1007/s002530051136
31. Plückthun A, Pack P. New protein engineering approaches to multivalent and bispecific antibody fragments. Immunotechnology (1997) 3:83-105. doi:10.1016/S1380-2933(97)00067-5
32. Choi BD, Kuan C-T, Cai M, Archer GE, Mitchell DA, Gedeon PC, et al. Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma. Proc Natl Acad Sci U S A (2013) 110:270-5. doi:10.1073/pnas.1219817110
33. Fournier P, Schirrmacher V. Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future. BioDrugs (2013) 27:35-53. doi:10.1007/s40259-012-0008-z
34. Zitron IM, Thakur A, Norkina O, Barger GR, Lum LG, Mittal S. Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies. BMC Cancer (2013) 13:83. doi:10.1186/1471-2407-13-83
35. Pant N, Hultberg A, Zhao Y, Svensson L, Pan-Hammarstrom Q, Johansen K, et al. Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea. J Infect Dis (2006) 194:1580-8. doi:10.1086/508747
36. Holt LJ, Herring C, Jespers LS, Woolven BP, Tomlinson IM. Domain antibodies: proteins for therapy. Trends Biotechnol (2003) 21:484-90. doi:10.1016/j.tibtech.2003.08.007
37. Tang Z, Feng M, Gao W, Phung Y, Chen W, Chaudhary A, et al. A human single-domain antibody elicits potent anti-tumor activity by targeting an epitope in mesothelin close to the cancer cell surface. Mol Cancer Ther (2013) 12:416-26. doi:10.1158/1535-7163.MCT-12-0731
38. Powers DB, Amersdorfer P, Poul M, Nielsen UB, Shalaby MR, Adams GP, et al. Expression of single-chain Fv-Fc fusions in Pichia pastoris. J Immunol Methods (2001) 251:123-35. doi:10.1016/S0022-1759(00)00290-8
39. Wan L, Zhu S, Zhu J, Yang H, Li S, Li Y, et al. Production and characterization of a CD25-specific scFv-Fc antibody secreted from Pichia pastoris. Appl Microbiol Biotechnol (2012) 97:3855-63. doi:10.1007/s00253-012-4632-9
40. Ni Y, Chen R. Extracellular recombinant protein production from Escherichia coli. Biotechnol Lett (2009) 31:1661-70. doi:10.1007/s10529-009-0077-3
41. Schmidt FR. Recombinant expression systems in the pharmaceutical industry. Appl Microbiol Biotechnol (2004) 65:363-72. doi:10.1007/s00253-004-1656-9
42. Terpe K. Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol (2006) 72:211-22. doi:10.1007/s00253-006-0465-8
43. Skerra A, Plückthun A. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science (1988) 240:1038-41. doi:10.1126/science.3285470
44. Better M, Chang CP, Robinson RR, Horwitz AH. Escherichia coli secretion of an active chimeric antibody fragment. Science (1988) 240:1041-3. doi:10.1126/science.3285471
45. Wörn A, Auf der Maur A, Escher D, Honegger A, Barberis A, Plückthun A. Correlation between in vitro stability and in vivo performance of anti-GCN4 intrabodies as cytoplasmic inhibitors. J Biol Chem (2000) 275:2795-803. doi:10.1074/jbc.275.4.2795
46. Martineau P, Jones P, Winter G. Expression of an antibody fragment at high levels in the bacterial cytoplasm. J Mol Biol (1998) 280:117-27. doi:10.1006/jmbi.1998.1840
47. Proba K, Wörn A, Honegger A, Plückthun A. Antibody scFv fragments without disulfide bonds made by molecular evolution. J Mol Biol (1998) 275:245-53. doi:10.1006/jmbi.1997.1457
48. Wörn A, Plückthun A. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability. Biochemistry (1998) 37:13120-7. doi:10.1021/bi980712q
49. Levy R, Weiss R, Chen G, Iverson BL, Georgiou G. Production of correctly folded Fab antibody fragment in the cytoplasm of Escherichia coli trxB gor mutants via the coexpression of molecular chaperones. Protein Expr Purif (2001) 23:338-47. doi:10.1006/prep.2001.1520
50. Veggiani G, de Marco A. Improved quantitative and qualitative production of single-domain intrabodies mediated by the co-expression of Erv1p sulfhydryl oxidase. Protein Expr Purif (2011) 79:111-4. doi:10.1016/j.pep.2011.03.005
51. Rusch SL, Kendall DA. Interactions that drive Sec-dependent bacterial protein transport. Biochemistry (2007) 46:9665-73. doi:10.1021/bi7010064
52. Ge L, Knappik A, Pack P, Freund C, Plückthun A. Expressing Antibodies in Escherichia coli, in: Antibody Engineering. New York: Oxford University Press (1995). p. 229-66.
53. Sletta H, Tøndervik A, Hakvåg S, Aune TEV, Nedal A, Aune R, et al. The presence of N-terminal secretion signal sequences leads to strong stimulation of the total expression levels of three tested medically important proteins during high-cell-density cultivations of Escherichia coli. Appl Environ Microbiol (2007) 73:906-12. doi:10.1128/AEM.01804-06
54. Tachibana H, Takekoshi M, Cheng X-J, Nakata Y, Takeuchi T, Ihara S. Bacterial expression of a human monoclonal antibody-alkaline phosphatase conjugate specific for Entamoeba histolytica. Clin Diagn Lab Immunol (2004) 11:216-8.
55. Thie H, Schirrmann T, Paschke M, Dübel S, Hust M. SRP and Sec pathway leader peptides for antibody phage display and antibody fragment production in E. coli. N Biotechnol (2008) 25:49-54. doi:10.1016/j.nbt.2008.01.001
56. Kirsch M, Zaman M, Meier D, Dübel S, Hust M. Parameters affecting the display of antibodies on phage. J Immunol Methods (2005) 301:173-85. doi:10.1016/j.jim.2005.04.017
57. Ward ES. Antibody engineering using Escherichia coli as host. Adv Pharmacol (1993) 24:1-20. doi:10.1016/S1054-3589(08)60931-X
58. Hust M, Steinwand M, Al-Halabi L, Helmsing S, Schirrmann T, Dübel S. Improved microtitre plate production of single chain Fv fragments in Escherichia coli. N Biotechnol (2009) 25:424-8. doi:10.1016/j.nbt.2009.03.004
59. Lauer B, Ottleben I, Jacobsen H-J, Reinard T. Production of a single-chain variable fragment antibody against fumonisin B1. J Agric Food Chem (2005) 53:899-904. doi:10.1021/jf048651s
60. Mersmann M, Meier D, Mersmann J, Helmsing S, Nilsson P, Gräslund S, et al. Towards proteome scale antibody selections using phage display. N Biotechnol (2010) 27:118-28. doi:10.1016/j.nbt.2009.10.007
61. Mi J, Yan J, Guo Z, Zhao M, Chang W. Isolation and characterization of an anti-recombinant erythropoietin single-chain antibody fragment using a phage display antibody library. Anal Bioanal Chem (2005) 383:218-23. doi:10.1007/s00216-005-3401-3
62. Bothmann H, Plückthun A. Selection for a periplasmic factor improving phage display and functional periplasmic expression. Nat Biotechnol (1998) 16:376-80. doi:10.1038/nbt0498-376
63. Bothmann H, Pluckthun A. The periplasmic Escherichia coli peptidyl prolyl cis, trans-isomerase FkpA. I. Increased functional expression of antibody fragments with and without cis-prolines. J Biol Chem (2000) 275:17100-5. doi:10.1074/jbc. M910233199
64. Friedrich L, Stangl S, Hahne H, Küster B, Köhler P, MulthoffG, et al. Bacterial production and functional characterization of the Fab fragment of the murine IgG1/lambda monoclonal antibody cmHsp70.1, a reagent for tumour diagnostics. Protein Eng Des Sel (2010) 23:161-8. doi:10.1093/protein/gzp095
65. Ramm K, Plückthun A. The periplasmic Escherichia coli peptidyl prolyl cis, trans-isomerase FkpA. II. Isomerase-independent chaperone activity in vitro. J Biol Chem (2000) 275:17106-13. doi:10.1074/jbc. M910234199
66. Wiebe JC, Schüller C, Reiche JA, Kramer K, Skerra A, Hock B. An expression system for the E. coli fermentation of recombinant antibody Fab fragments from mice and rabbits. J AOAC Int (2010) 93:80-8.
67. Miethe S, Meyer T, Wöhl-Bruhn S, Frenzel A, Schirrmann T, Dübel S, et al. Production of single chain fragment variable (scFv) antibodies in Escherichia coli using the LEXTM bioreactor. J Biotechnol (2012) 163:105-11. doi:10.1016/j.jbiotec.2012.07.011
68. Sletta H, Nedal A, Aune TEV, Hellebust H, Hakvåg S, Aune R, et al. Broad-host-range plasmid pJB658 can be used for industrial-level production of a secreted host-toxic single-chain antibody fragment in Escherichia coli. Appl Environ Microbiol (2004) 70:7033-9. doi:10.1128/AEM.70.12.7033-7039.2004
69. Kipriyanov SM, Moldenhauer G, Little M. High level production of soluble single chain antibodies in small-scale Escherichia coli cultures. J Immunol Methods (1997) 200:69-77. doi:10.1016/S0022-1759(96)00188-3
70. Thie H, Binius S, Schirrmann T, Hust M, Dübel S. Multimerization domains for antibody phage display and antibody production. N Biotechnol (2009) 26:314-21. doi:10.1016/j.nbt.2009.07.005
71. Zhao J-B, Wei D-Z, Tong W-Y. Identification of Escherichia coli host cell for high plasmid stability and improved production of antihuman ovarian carcinoma x antihuman CD3 single-chain bispecific antibody. Appl Microbiol Biotechnol (2007) 76:795-800. doi:10.1007/s00253-007-1050-5
72. Mazor Y, Van Blarcom T, Mabry R, Iverson BL, Georgiou G. Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli. Nat Biotechnol (2007) 25:563-5. doi:10.1038/nbt1296
73. Simmons LC, Reilly D, Klimowski L, Raju TS, Meng G, Sims P, et al. Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies. J Immunol Methods (2002) 263:133-47. doi:10.1016/S0022-1759(02)00036-4
74. Rippmann JF, Klein M, Hoischen C, Brocks B, Rettig WJ, Gumpert J, et al. Procaryotic expression of single-chain variable-fragment (scFv) antibodies: secretion in L-form cells of Proteus mirabilis leads to active product and overcomes the limitations of periplasmic expression in Escherichia coli. Appl Environ Microbiol (1998) 64:4862-9.
75. Dammeyer T, Steinwand M, Krüger S-C, Dübel S, Hust M, Timmis KN. Efficient production of soluble recombinant single chain Fv fragments by a Pseudomonas putida strain KT2440 cell factory. Microb Cell Fact (2011) 10:11. doi:10.1186/1475-2859-10-11
76. Inoue Y, Ohta T, Tada H, Iwasa S, Udaka S, Yamagata H. Efficient production of a functional mouse/human chimeric Fab' against human urokinase-type plasminogen activator by Bacillus brevis. Appl Microbiol Biotechnol (1997) 48:487-92. doi:10.1007/s002530051084
77. Shiroza T, Shinozaki-Kuwahara N, Hayakawa M, Shibata Y, Hashizume T, Fukushima K, et al. Production of a single-chain variable fraction capable of inhibiting the Streptococcus mutans glucosyltransferase in Bacillus brevis: construction of a chimeric shuttle plasmid secreting its gene product. Biochim Biophys Acta (2003) 1626:57-64. doi:10.1016/S0167-4781(03)00038-1
78. Wu SC, Ye R, Wu XC, Ng SC, Wong SL. Enhanced secretory production of a single-chain antibody fragment from Bacillus subtilis by co-production of molecular chaperones. J Bacteriol (1998) 180:2830-5.
79. Wu S-C, Yeung JC, Duan Y, Ye R, Szarka SJ, Habibi HR, et al. Functional production and characterization of a fibrin-specific single-chain antibody fragment from Bacillus subtilis: effects of molecular chaperones and a wall-bound protease on antibody fragment production. Appl Environ Microbiol (2002) 68:3261-9. doi:10.1128/AEM.68.7.3261-3269.2002
80. David F, Steinwand M, Hust M, Bohle K, Ross A, Dübel S, et al. Antibody production in Bacillus megaterium: strategies and physiological implications of scaling from microtiter plates to industrial bioreactors. Biotechnol J (2011) 6:1516-31. doi:10.1002/biot.201000417
81. David F, Westphal R, Bunk B, Jahn D, Franco-Lara E. Optimization of antibody fragment production in Bacillus megaterium: the role of metal ions on protein secretion. J Biotechnol (2010) 150:115-24. doi:10.1016/j.jbiotec.2010.07.023
82. Jordan E, Al-Halabi L, Schirrmann T, Hust M. Antibody production by the Gram-positive bacterium Bacillus megaterium. Methods Mol Biol (2009) 525:509-16. doi:10.1007/978-1-59745-554-1_27
83. Jordan E, Al-Halabi L, Schirrmann T, Hust M, Dübel S. Production of single chain Fab (scFab) fragments in Bacillus megaterium. Microb Cell Fact (2007) 6:38. doi:10.1186/1475-2859-6-2
84. Jordan E, Hust M, Roth A, Biedendieck R, Schirrmann T, Jahn D, et al. Production of recombinant antibody fragments in Bacillus megaterium. Microb Cell Fact (2007) 6:2. doi:10.1186/1475-2859-6-2
85. Lüders S, David F, Steinwand M, Jordan E, Hust M, Dübel S, et al. Influence of the hydromechanical stress and temperature on growth and antibody fragment production with Bacillus megaterium. Appl Microbiol Biotechnol (2011) 91:81-90. doi:10.1007/s00253-011-3193-7
86. Vary PS. Prime time for Bacillus megaterium. Microbiology (1994) 140(Pt 5):1001-13. doi:10.1099/13500872-140-5-1001
87. Chancey CJ, Khanna KV, Seegers JFML, Zhang GW, Hildreth J, Langan A, et al. Lactobacilli-expressed single-chain variable fragment (scFv) specific for intercellular adhesion molecule 1 (ICAM-1) blocks cell-associated HIV-1 transmission across a cervical epithelial monolayer. J Immunol (2006) 176:5627-36.
88. Krüger C, Hu Y, Pan Q, Marcotte H, Hultberg A, Delwar D, et al. In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat Biotechnol (2002) 20:702-6. doi:10.1038/nbt0702-702
89. Marcotte H, Kõll-Klais P, Hultberg A, Zhao Y, Gmür R, Mändar R, et al. Expression of single-chain antibody against RgpA protease of Porphyromonas gingivalis in Lactobacillus. J Appl Microbiol (2006) 100:256-63. doi:10.1111/j.1365-2672.2005.02786.x
90. De Pourcq K, Vervecken W, Dewerte I, Valevska A, Van Hecke A, Callewaert N. Engineering the yeast Yarrowia lipolytica for the production of therapeutic proteins homogeneously glycosylated with Man8GlcNAc2 and Man5GlcNAc2. Microb Cell Fact (2012) 11:53. doi:10.1186/1475-2859-11-53
91. Schreuder MP, Mooren AT, Toschka HY, Verrips CT, Klis FM. Immobilizing proteins on the surface of yeast cells. Trends Biotechnol (1996) 14:115-20. doi:10.1016/0167-7799(96)10017-2
92. Jeong KJ, Jang SH, Velmurugan N. Recombinant antibodies: engineering and production in yeast and bacterial hosts. Biotechnol J (2011) 6:16-27. doi:10.1002/biot.201000381
93. Davis GT, Bedzyk WD, Voss EW, Jacobs TW. Single chain antibody (SCA) encoding genes: one-step construction and expression in eukaryotic cells. Biotechnology N Y (1991) 9:165-9. doi:10.1038/nbt0291-165
94. Fleer R. Engineering yeast for high level expression. Curr Opin Biotechnol (1992) 3:486-96. doi:10.1016/0958-1669(92)90076-U
95. Buckholz RG, Gleeson MA. Yeast systems for the commercial production of heterologous proteins. Biotechnology N Y (1991) 9:1067-72. doi:10.1038/nbt1191-1067
96. Gasser B, Maurer M, Gach J, Kunert R, Mattanovich D. Engineering of Pichia pastoris for improved production of antibody fragments. Biotechnol Bioeng (2006) 94:353-61. doi:10.1002/bit.20851
97. Emberson LM, Trivett AJ, Blower PJ, Nicholls PJ. Expression of an anti-CD33 single-chain antibody by Pichia pastoris. J Immunol Methods (2005) 305:135-51. doi:10.1016/j.jim.2005.04.005
98. Ridder R, Schmitz R, Legay F, Gram H. Generation of rabbit monoclonal antibody fragments from a combinatorial phage display library and their production in the yeast Pichia pastoris. Biotechnology N Y (1995) 13:255-60. doi:10.1038/nbt0395-255
99. Gurkan C, Symeonides SN, Ellar DJ. High-level production in Pichia pastoris of an anti-p185HER-2 single-chain antibody fragment using an alternative secretion expression vector. Biotechnol Appl Biochem (2004) 39:115-22. doi:10.1042/BA20030096
100. Eldin P, Pauza ME, Hieda Y, Lin G, Murtaugh MP, Pentel PR, et al. High-level secretion of two antibody single chain Fv fragments by Pichia pastoris. J Immunol Methods (1997) 201:67-75. doi:10.1016/S0022-1759(96)00213-X
101. Damasceno LM, Anderson KA, Ritter G, Cregg JM, Old LJ, Batt CA. Cooverexpression of chaperones for enhanced secretion of a single-chain antibody fragment in Pichia pastoris. Appl Microbiol Biotechnol (2007) 74:381-9. doi:10.1007/s00253-006-0652-7
102. Frenken LG, van der Linden RH, Hermans PW, Bos JW, Ruuls RC, de Geus B, et al. Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J Biotechnol (2000) 78:11-21. doi:10.1016/S0168-1656(99)00228-X
103. Liu J, Wei D, Qian F, Zhou Y, Wang J, Ma Y, et al. pPIC9-Fc: a vector system for the production of single-chain Fv-Fc fusions in Pichia pastoris as detection reagents in vitro. J Biochem (2003) 134:911-7. doi:10.1093/jb/mvg222
104. Horwitz AH, Chang CP, Better M, Hellstrom KE, Robinson RR. Secretion of functional antibody and Fab fragment from yeast cells. Proc Natl Acad Sci U S A (1988) 85:8678-82. doi:10.1073/pnas.85.22.8678
105. Potgieter TI, Kersey SD, Mallem MR, Nylen AC, d'Anjou M. Antibody expression kinetics in glycoengineered Pichia pastoris. Biotechnol Bioeng (2010) 106:918-27. doi:10.1002/bit.22756
106. Van der Linden RH, de Geus B, Frenken GJ, Peters H, Verrips CT. Improved production and function of llama heavy chain antibody fragments by molecular evolution. J Biotechnol (2000) 80:261-70. doi:10.1016/S0168-1656(00)00274-1
107. Shusta EV, Raines RT, Plückthun A, Wittrup KD. Increasing the secretory capacity of Saccharomyces cerevisiae for production of single-chain antibody fragments. Nat Biotechnol (1998) 16:773-7. doi:10.1038/nbt0898-773
108. Grinna LS, Tschopp JF. Size distribution and general structural features of N-linked oligosaccharides from the methylotrophic yeast, Pichia pastoris. Yeast (1989) 5:107-15. doi:10.1002/yea.320050206
109. Choi B-K, Bobrowicz P, Davidson RC, Hamilton SR, Kung DH, Li H, et al. Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris. Proc Natl Acad Sci U S A (2003) 100:5022-7. doi:10.1073/pnas.0931263100
110. Hamilton SR, Davidson RC, Sethuraman N, Nett JH, Jiang Y, Rios S, et al. Humanization of yeast to produce complex terminally sialylated glycoproteins. Science (2006) 313:1441-3. doi:10.1126/science.1130256
111. Hamilton SR, Bobrowicz P, Bobrowicz B, Davidson RC, Li H, Mitchell T, et al. Production of complex human glycoproteins in yeast. Science (2003) 301:1244-6. doi:10.1126/science.1088166
112. Li H, Sethuraman N, Stadheim TA, Zha D, Prinz B, Ballew N, et al. Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nat Biotechnol (2006) 24:210-5. doi:10.1038/nbt1178
113. Potgieter TI, Cukan M, Drummond JE, Houston-Cummings NR, Jiang Y, Li F, et al. Production of monoclonal antibodies by glycoengineered Pichia pastoris. J Biotechnol (2009) 139:318-25. doi:10.1016/j.jbiotec.2008.12.015
114. Zhang N, Liu L, Dumitru CD, Cummings NRH, Cukan M, Jiang Y, et al. Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study. MAbs (2011) 3:289-98. doi:10.4161/mabs.3.3.15532
115. Ye J, Ly J, Watts K, Hsu A, Walker A, McLaughlin K, et al. Optimization of a glycoengineered Pichia pastoris cultivation process for commercial antibody production. Biotechnol Prog (2011) 27:1744-50. doi:10.1002/btpr.695
116. Jiang Y, Li F, Button M, Cukan M, Moore R, Sharkey N, et al. A high-throughput purification of monoclonal antibodies from glycoengineered Pichia pastoris. Protein Expr Purif (2010) 74:9-15. doi:10.1016/j.pep.2010.04.016
117. Joosten V, Lokman C, Van Den Hondel CA, Punt PJ. The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi. Microb Cell Fact (2003) 2:1. doi:10.1186/1475-2859-2-1
118. Ward M, Lin C, Victoria DC, Fox BP, Fox JA, Wong DL, et al. Characterization of humanized antibodies secreted by Aspergillus niger. Appl Environ Microbiol (2004) 70:2567-76. doi:10.1128/AEM.70.5.2567-2576.2004
119. Joosten V, Gouka RJ, van den Hondel CAMJJ, Verrips CT, Lokman BC. Expression and production of llama variable heavy-chain antibody fragments (V(HH)s) by Aspergillus awamori. Appl Microbiol Biotechnol (2005) 66:384-92. doi:10.1007/s00253-004-1689-0
120. Frenken LG, Hessing JG, Van den Hondel CA, Verrips CT. Recent advances in the large-scale production of antibody fragments using lower eukaryotic microorganisms. Res Immunol (1998) 149:589-99. doi:10.1016/S0923-2494(98)80011-4
121. Nyyssönen E, Penttilä M, Harkki A, Saloheimo A, Knowles JK, Keränen S. Efficient production of antibody fragments by the filamentous fungus Trichoderma reesei. Biotechnology N Y (1993) 11:591-5. doi:10.1038/nbt0593-591
122. Joosten V, Roelofs MS, van den Dries N, Goosen T, Verrips CT, van den Hondel CAMJJ, et al. Production of bifunctional proteins by Aspergillus awamori: llama variable heavy chain antibody fragment (V(HH)) R9 coupled to Arthromyces ramosus peroxidase (ARP). J Biotechnol (2005) 120:347-59. doi:10.1016/j.jbiotec.2005.06.034
123. Okazaki F, Aoki J, Tabuchi S, Tanaka T, Ogino C, Kondo A. Efficient heterologous expression and secretion in Aspergillus oryzae of a llama variable heavy-chain antibody fragment V(HH) against EGFR. Appl Microbiol Biotechnol (2012) 96:81-8. doi:10.1007/s00253-012-4158-1
124. Verdoes JC, Punt PJ, Burlingame R, Bartels J, Dijk R, van Slump E, et al. ORIGINAL RESEARCH: a dedicated vector for efficient library construction and high throughput screening in the hyphal fungus Chrysosporium lucknowense. Ind Biotechnol (2007) 3:48-57. doi:10.1089/ind.2007.3.048
125. Basile G, Peticca M. Recombinant protein expression in Leishmania tarentolae. Mol Biotechnol (2009) 43:273-8. doi:10.1007/s12033-009-9213-5
126. Niimi T. Recombinant protein production in the eukaryotic protozoan parasite Leishmania tarentolae: a review. Methods Mol Biol (2012) 824:307-15. doi:10.1007/978-1-61779-433-9_15
127. Klatt S, Rohe M, Alagesan K, Kolarich D, Konthur Z, Hartl D. Production of glycosylated soluble amyloid precursor protein alpha (sAPPalpha) in Leishmania tarentolae. J Proteome Res (2013) 12:396-403. doi:10.1021/pr300693f
128. Klatt S, Konthur Z. Secretory signal peptide modification for optimized antibody-fragment expression-secretion in Leishmania tarentolae. Microb Cell Fact (2012) 11:97. doi:10.1186/1475-2859-11-97
129. Condreay JP, Witherspoon SM, Clay WC, Kost TA. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci U S A (1999) 96:127-32. doi:10.1073/pnas.96.1.127
130. Hofmann C, Sandig V, Jennings G, Rudolph M, Schlag P, Strauss M. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci U S A (1995) 92:10099-103. doi:10.1073/pnas.92.22.10099
131. Davis TR, Wickham TJ, McKenna KA, Granados RR, Shuler ML, Wood HA. Comparative recombinant protein production of eight insect cell lines. In vitro Cell Dev Biol Anim (1993) 29A:388-90. doi:10.1007/BF02633986
132. Kretzschmar T, Aoustin L, Zingel O, Marangi M, Vonach B, Towbin H, et al. High-level expression in insect cells and purification of secreted monomeric singlechain Fv antibodies. J Immunol Methods (1996) 195:93-101. doi:10.1016/0022-1759(96)00093-2
133. Liang M, Dübel S, Li D, Queitsch I, Li W, Bautz EK. Baculovirus expression cassette vectors for rapid production of complete human IgG from phage display selected antibody fragments. J Immunol Methods (2001) 247:119-30. doi:10.1016/S0022-1759(00)00322-7
134. Hsu TA, Takahashi N, Tsukamoto Y, Kato K, Shimada I, Masuda K, et al. Differential N-glycan patterns of secreted and intracellular IgG produced in Trichoplusia ni cells. J Biol Chem (1997) 272:9062-70. doi:10.1074/jbc.272.14.9062
135. Jin BR, Ryu CJ, Kang SK, Han MH, Hong HJ. Characterization of a murine-human chimeric antibody with specificity for the pre-S2 surface antigen of hepatitis B virus expressed in baculovirus-infected insect cells. Virus Res (1995) 38:269-77. doi:10.1016/0168-1702(95)00051-Q
136. Zu Putlitz J, Kubasek WL, Duchêne M, Marget M, von Specht BU, Domdey H. Antibody production in baculovirus-infected insect cells. Biotechnology N Y (1990) 8:651-4. doi:10.1038/nbt0790-651
137. Edelman L, Margaritte C, Chaabihi H, Monchâtre E, Blanchard D, Cardona A, et al. Obtaining a functional recombinant anti-rhesus (D) antibody using the baculovirus-insect cell expression system. Immunology (1997) 91:13-9. doi:10.1046/j.1365-2567.1997.00219.x
138. Ailor E, Betenbaugh MJ. Modifying secretion and post-translational processing in insect cells. Curr Opin Biotechnol (1999) 10:142-5. doi:10.1016/S0958-1669 (99)80024-X
139. Aumiller JJ, Mabashi-Asazuma H, Hillar A, Shi X, Jarvis DL. A new glycoengineered insect cell line with an inducibly mammalianized protein N-glycosylation pathway. Glycobiology (2012) 22:417-28. doi:10.1093/glycob/cwr160
140. Jarvis DL. Developing baculovirus-insect cell expression systems for humanized recombinant glycoprotein production. Virology (2003) 310:1-7. doi:10.1016/S0042-6822(03)00120-X
141. Tomiya N, Betenbaugh MJ, Lee YC. Humanization of lepidopteran insect-cell-produced glycoproteins. Acc Chem Res (2003) 36:613-20. doi:10.1021/ar020202v
142. Hasemann CA, Capra JD. High-level production of a functional immunoglobulin heterodimer in a baculovirus expression system. Proc Natl Acad Sci U S A (1990) 87:3942-6. doi:10.1073/pnas.87.10.3942
143. Hsu TA, Betenbaugh MJ. Coexpression of molecular chaperone BiP improves immunoglobulin solubility and IgG secretion from Trichoplusia ni insect cells. Biotechnol Prog (1997) 13:96-104. doi:10.1021/bp960088d
144. Reavy B, Ziegler A, Diplexcito J, MacIntosh SM, Torrance L, Mayo M. Expression of functional recombinant antibody molecules in insect cell expression systems. Protein Expr Purif (2000) 18:221-8. doi:10.1006/prep.1999.1191
145. Seamans TC, Gould SL, DiStefano DJ, Silberklang M, Robinson DK. Use of lipid emulsions as nutritional supplements in mammalian cell culture. Ann N Y Acad Sci (1994) 745:240-3. doi:10.1111/j.1749-6632.1994.tb44377.x
146. Wurm FM. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol (2004) 22:1393-8. doi:10.1038/nbt1026
147. Jones D, Kroos N, Anema R, van Montfort B, Vooys A, van der Kraats S, et al. High-level expression of recombinant IgG in the human cell line per.c6. Biotechnol Prog (2003) 19:163-8. doi:10.1021/bp025574h
148. Butler M. Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals. Appl Microbiol Biotechnol (2005) 68:283-91. doi:10.1007/s00253-005-1980-8
149. Fussenegger M, Bailey JE. Molecular regulation of cell-cycle progression and apoptosis in mammalian cells: implications for biotechnology. Biotechnol Prog (1998) 14:807-33. doi:10.1021/bp9800891
150. Lifely MR, Hale C, Boyce S, Keen MJ, Phillips J. Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions. Glycobiology (1995) 5:813-22. doi:10.1093/glycob/5.8.813
151. Niklas J, Schräder E, Sandig V, Noll T, Heinzle E. Quantitative characterization of metabolism and metabolic shifts during growth of the new human cell line AGE1.HN using time resolved metabolic flux analysis. Bioprocess Biosyst Eng (2011) 34:533-45. doi:10.1007/s00449-010-0502-y
152. Shields RL, Lai J, Keck R, O'Connell LY, Hong K, Meng YG, et al. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem (2002) 277:26733-40. doi:10.1074/jbc. M202069200
153. Le Hir H, Nott A, Moore MJ. How introns influence and enhance eukaryotic gene expression. Trends Biochem Sci (2003) 28:215-20. doi:10.1016/S0968-0004 (03)00052-5
154. Nott A, Le Hir H, Moore MJ. Splicing enhances translation in mammalian cells: an additional function of the exon junction complex. Genes Dev (2004) 18:210-22. doi:10.1101/gad.1163204
155. Li J, Menzel C, Meier D, Zhang C, Dübel S, Jostock T. A comparative study of different vector designs for the mammalian expression of recombinant IgG antibodies. J Immunol Methods (2007) 318:113-24. doi:10.1016/j.jim.2006.10.010
156. Li J, Zhang C, Jostock T, Dübel S. Analysis of IgG heavy chain to light chain ratio with mutant Encephalomyocarditis virus internal ribosome entry site. Protein Eng Des Sel (2007) 20:491-6. doi:10.1093/protein/gzm038
157. Omasa T. Gene amplification and its application in cell and tissue engineering. J Biosci Bioeng (2002) 94:600-5. doi:10.1016/S1389-1723(02)80201-8
158. Peakman TC, Worden J, Harris RH, Cooper H, Tite J, Page MJ, et al. Comparison of expression of a humanized monoclonal antibody in mouse NSO myeloma cells and Chinese hamster ovary cells. Hum Antibodies Hybridomas (1994) 5:65-74.
159. Spier RE, Griffiths JB, Berthold W. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann Limited (1994).
160. Zhou W, Chen CC, Buckland B, Aunins J. Fed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production. Biotechnol Bioeng (1997) 55:783-92. doi:10.1002/(SICI)1097-0290(19970905)55:5
161. Jostock T. Expression of antibody in mammalian cells. In: Al-Rubeai M editor. Antibody Expression and Production, Cell Engineering. Netherlands: Springer (2011). p. 1-24.
162. Girod P-A, Mermod N. Use of scaffold/matrix-attachment regions for protein production. In: Makrides SC editor. New Comprehensive Biochemistry. Amsterdam, NL: Elsevier (2003). p. 359-79.
163. Antoniou M, Harland L, Mustoe T, Williams S, Holdstock J, Yague E, et al. Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. Genomics (2003) 82:269-79. doi:10.1016/S0888-7543(03)00107-1
164. Kwaks THJ, Barnett P, Hemrika W, Siersma T, Sewalt RGAB, Satijn DPE, et al. Identification of anti-repressor elements that confer high and stable protein production in mammalian cells. Nat Biotechnol (2003) 21:553-8. doi:10.1038/nbt814
165. Fernández LA, Winkler M, Grosschedl R. Matrix attachment region-dependent function of the immunoglobulin mu enhancer involves histone acetylation at a distance without changes in enhancer occupancy. Mol Cell Biol (2001) 21:196-208. doi:10.1128/MCB.21.1.196-208.2001
166. Zahn-Zabal M, Kobr M, Girod PA, Imhof M, Chatellard P, de Jesus M, et al. Development of stable cell lines for production or regulated expression using matrix attachment regions. J Biotechnol (2001) 87:29-42. doi:10.1016/S0168-1656(00)00423-5
167. Gorman CM, Howard BH, Reeves R. Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate. Nucleic Acids Res (1983) 11:7631-48. doi:10.1093/nar/11.21.7631
168. Classon BJ, Brown MH, Garnett D, Somoza C, Barclay AN, Willis AC, et al. The hinge region of the CD8 alpha chain: structure, antigenicity, and utility in expression of immunoglobulin superfamily domains. Int Immunol (1992) 4:215-25. doi:10.1093/intimm/4.2.215
169. Kober L, Zehe C, Bode J. Development of a novel ER stress based selection system for the isolation of highly productive clones. Biotechnol Bioeng (2012) 109:2599-611. doi:10.1002/bit.24527
170. Nehlsen K, Schucht R, da Gama-Norton L, Krömer W, Baer A, Cayli A, et al. Recombinant protein expression by targeting pre-selected chromosomal loci. BMC Biotechnol (2009) 9:100. doi:10.1186/1472-6750-9-100
171. Fang J, Yi S, Simmons A, Tu GH, Nguyen M, Harding TC, et al. An antibody delivery system for regulated expression of therapeutic levels of monoclonal antibodies in vivo. Mol Ther (2007) 15:1153-9.
172. Jostock T, Dragic Z, Fang J, Jooss K, Wilms B, Knopf H-P. Combination of the 2A/furin technology with an animal component free cell line development platform process. Appl Microbiol Biotechnol (2010) 87:1517-24. doi:10.1007/s00253-010-2625-0
173. Wilke S, Groebe L, Maffenbeier V, Jäger V, Gossen M, Josewski J, et al. Streamlining homogeneous glycoprotein production for biophysical and structural applications by targeted cell line development. PLoS ONE (2011) 6:e27829. doi:10.1371/journal.pone.0027829
174. Geisse S, Fux C. Recombinant protein production by transient gene transfer into Mammalian cells. Methods Enzymol (2009) 463:223-38. doi:10.1016/S0076-6879(09)63015-9
175. Baldi L, Hacker DL, Adam M, Wurm FM. Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives. Biotechnol Lett (2007) 29:677-84. doi:10.1007/s10529-006-9297-y
176. Jostock T, Vanhove M, Brepoels E, Van Gool R, Daukandt M, Wehnert A, et al. Rapid generation of functional human IgG antibodies derived from Fab-on-phage display libraries. J Immunol Methods (2004) 289:65-80. doi:10.1016/j.jim.2004.03.014
177. Backliwal G, Hildinger M, Chenuet S, Wulhfard S, De Jesus M, Wurm FM. Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions. Nucleic Acids Res (2008) 36:e96. doi:10.1093/nar/gkn423
178. Geisse S, Henke M. Large-scale transient transfection of mammalian cells: a newly emerging attractive option for recombinant protein production. J Struct Funct Genomics (2005) 6:165-70. doi:10.1007/s10969-005-2826-4
179. Tuvesson O, Uhe C, Rozkov A, Lüllau E. Development of a generic transient transfection process at 100 L scale. Cytotechnology (2008) 56:123-36. doi:10.1007/s10616-008-9135-2
180. Meissner P, Pick H, Kulangara A, Chatellard P, Friedrich K, Wurm FM. Transient gene expression: recombinant protein production with suspension-adapted HEK293-EBNA cells. Biotechnol Bioeng (2001) 75:197-203. doi:10.1002/bit.1179
181. Boussif O, Zanta MA, Behr JP. Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther (1996) 3:1074-80.
182. Thomas M, Klibanov AM. Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A (2002) 99:14640-5. doi:10.1073/pnas.192581499
183. Loignon M, Perret S, Kelly J, Boulais D, Cass B, Bisson L, et al. Stable high volumetric production of glycosylated human recombinant IFNalpha2b in HEK293 cells. BMC Biotechnol (2008) 8:65. doi:10.1186/1472-6750-8-65
184. Zhang J, MacKenzie R, Durocher Y. Production of chimeric heavy-chain antibodies. Methods Mol Biol (2009) 525:323-36. doi:10.1007/978-1-59745-554-1_17
185. Daniell H, Streatfield SJ, WycoffK. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci (2001) 6:219-26. doi:10.1016/S1360-1385(01)01922-7
186. Hellens RP, Edwards EA, Leyland NR, Bean S, Mullineaux PM. pGreen: a versatile and flexible binary Ti vector for Agrobacterium-mediated plant transformation. Plant Mol Biol (2000) 42:819-32. doi:10.1023/A:1006496308160
187. Hoekema A, Hirsch PR, Hooykaas PJJ, Schilperoort RA. A binary plant vector strategy based on separation of vir- and T-region of the Agrobacterium tumefaciens Ti-plasmid. Nature (1983) 303:179-80. doi:10.1038/303179a0
188. Amian AA, Papenbrock J, Jacobsen H-J, Hassan F. Enhancing transgenic pea (Pisum sativum L.) resistance against fungal diseases through stacking of two antifungal genes (chitinase and glucanase). GM Crops (2011) 2:104-9. doi:10.4161/gmcr.2.2.16125
189. Horsch RB, Fry JE, Hofmann NL, Eichholz D, Rogers SG, Fraley RT. A simple and general method for transferring genes into plants. Science (1985) 227:1229-31. doi:10.1126/science.227.4691.1229
190. McCormick AA, Reinl SJ, Cameron TI, Vojdani F, Fronefield M, Levy R, et al. Individualized human scFv vaccines produced in plants: humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig. J Immunol Methods (2003) 278:95-104. doi:10.1016/S0022-1759(03)00208-4
191. McCormick AA, Reddy S, Reinl SJ, Cameron TI, Czerwinkski DK, Vojdani F, et al. Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study. Proc Natl Acad Sci U S A (2008) 105:10131-6. doi:10.1073/pnas.0803636105
192. Gomord V, Chamberlain P, Jefferis R, Faye L. Biopharmaceutical production in plants: problems, solutions and opportunities. Trends Biotechnol (2005) 23:559-65. doi:10.1016/j.tibtech.2005.09.003
193. Jin C, Altmann F, Strasser R, Mach L, Schähs M, Kunert R, et al. A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits. Glycobiology (2008) 18:235-41. doi:10.1093/glycob/cwm137
194. Walsh G, Jefferis R. Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol (2006) 24:1241-52. doi:10.1038/nbt1252
195. Gomord V, Denmat LA, Fitchette-Lainé AC, Satiat-Jeunemaitre B, Hawes C, Faye L. The C-terminal HDEL sequence is sufficient for retention of secretory proteins in the endoplasmic reticulum (ER) but promotes vacuolar targeting of proteins that escape the ER. Plant J (1997) 11:313-25. doi:10.1046/j.1365-313X.1997.11020313.x
196. Schouten A, Roosien J, de Boer JM, Wilmink A, Rosso MN, Bosch D, et al. Improving scFv antibody expression levels in the plant cytosol. FEBS Lett (1997) 415:235-41. doi:10.1016/S0014-5793(97)01129-0
197. Schouten A, Roosien J, van Engelen FA, de Jong GA, Borst-Vrenssen AW, Zilverentant JF, et al. The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco. Plant Mol Biol (1996) 30:781-93. doi:10.1007/BF00019011
198. Schähs M, Strasser R, Stadlmann J, Kunert R, Rademacher T, Steinkellner H. Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotechnol J (2007) 5:657-63. doi:10.1111/j.1467-7652.2007.00273.x
199. Strasser R, Stadlmann J, Schähs M, Stiegler G, Quendler H, Mach L, et al. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol J (2008) 6:392-402. doi:10.1111/j.1467-7652.2008.00330.x
200. Yin B-J, Gao T, Zheng N-Y, Li Y, Tang S-Y, Liang L-M, et al. Generation of glyco-engineered BY2 cell lines with decreased expression of plant-specific glycoepitopes. Protein Cell (2011) 2:41-7. doi:10.1007/s13238-011-1007-4
201. Vézina L-P, Faye L, Lerouge P, D'Aoust M-A, Marquet-Blouin E, Burel C, et al. Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotechnol J (2009) 7:442-55. doi:10.1111/j.1467-7652.2009.00414.x
202. Jez J, Castilho A, Grass J, Vorauer-Uhl K, Sterovsky T, Altmann F, et al. Expression of functionally active sialylated human erythropoietin in plants. Biotechnol J (2013) 8:371-82. doi:10.1002/biot.201200363
203. Castilho A, Neumann L, Daskalova S, Mason HS, Steinkellner H, Altmann F, et al. Engineering of sialylated mucin-type O-glycosylation in plants. J Biol Chem (2012) 287:36518-26. doi:10.1074/jbc. M112.402685
204. Yang Z, Drew DP, Jørgensen B, Mandel U, Bach SS, Ulvskov P, et al. Engineering mammalian mucin-type O-glycosylation in plants. J Biol Chem (2012) 287:11911-23. doi:10.1074/jbc. M111.312918
205. Mett V, Chichester JA, Stewart ML, Musiychuk K, Bi H, Reifsnyder CJ, et al. A non-glycosylated, plant-produced human monoclonal antibody against anthrax protective antigen protects mice and non-human primates from B. anthracis spore challenge. Hum Vaccin (2011) 7:183-90. doi:10.4161/hv.7.0.14586
206. Rodríguez M, Pérez L, Gavilondo JV, Garrido G, Bequet-Romero M, Hernández I, et al. Comparative in vitro and experimental in vivo studies of the antiepidermal growth factor receptor antibody nimotuzumab and its aglycosylated form produced in transgenic tobacco plants. Plant Biotechnol J (2013) 11:53-65. doi:10.1111/pbi.12006
207. Marillonnet S, Thoeringer C, Kandzia R, Klimyuk V, Gleba Y. Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nat Biotechnol (2005) 23:718-23. doi:10.1038/nbt1094
208. Giritch A, Marillonnet S, Engler C, van Eldik G, Botterman J, Klimyuk V, et al. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proc Natl Acad Sci U S A (2006) 103:14701-6. doi:10.1073/pnas.0606631103
209. Barros GOF, Woodard SL, Nikolov ZL. Phenolics removal from transgenic Lemna minor extracts expressing mAb and impact on mAb production cost. Biotechnol Prog (2011) 27:410-8. doi:10.1002/btpr.543
210. Naik AD, Menegatti S, Reese HR, Gurgel PV, Carbonell RG. Process for purification of monoclonal antibody expressed in transgenic Lemna plant extract using dextran-coated charcoal and hexamer peptide affinity resin. J Chromatogr A (2012) 1260:61-6. doi:10.1016/j.chroma.2012.08.043
211. Woodard SL, Wilken LR, Barros GOF, White SG, Nikolov ZL. Evaluation of monoclonal antibody and phenolic extraction from transgenic Lemna for purification process development. Biotechnol Bioeng (2009) 104:562-71. doi:10.1002/bit.22428
212. Torres E, Vaquero C, Nicholson L, Sack M, Stöger E, Drossard J, et al. Rice cell culture as an alternative production system for functional diagnostic and therapeutic antibodies. Transgenic Res (1999) 8:441-9. doi:10.1023/A:1008969031219
213. Buck SD, Virdi V, Meyer TD, Wilde KD, Piron R, Nolf J, et al. Production of Camel-like antibodies in plants. In: Saerens D, Muyldermans S editors. Single Domain Antibodies, Methods in Molecular Biology. Clifton, NJ: Humana Press (2012). p. 305-24.
214. De Wilde K, De Buck S, Vanneste K, Depicker A. Recombinant antibody production in Arabidopsis seeds triggers an unfolded protein response. Plant Physiol (2012) 161:1021-33. doi:10.1104/pp.112.209718
215. Bardor M, Loutelier-Bourhis C, Paccalet T, Cosette P, Fitchette A-C, Vézina L-P, et al. Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glyco-engineering into human-compatible structures. Plant Biotechnol J (2003) 1:451-62. doi:10.1046/j.1467-7652.2003.00041.x
216. He J, Lai H, Brock C, Chen Q. A novel system for rapid and cost-effective production of detection and diagnostic reagents of West Nile virus in plants. J Biomed Biotechnol (2012) 2012:106783. doi:10.1155/2012/106783
217. Rademacher T, Sack M, Arcalis E, Stadlmann J, Balzer S, Altmann F, et al. Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. Plant Biotechnol J (2008) 6:189-201. doi:10.1111/j.1467-7652.2007.00306.x
218. Ramessar K, Rademacher T, Sack M, Stadlmann J, Platis D, Stiegler G, et al. Cost-effective production of a vaginal protein microbicide to prevent HIV transmission. Proc Natl Acad Sci U S A (2008) 105:3727-32. doi:10.1073/pnas.0708841104
219. KirchhoffJ, Raven N, Boes A, Roberts JL, Russell S, Treffenfeldt W, et al. Monoclonal tobacco cell lines with enhanced recombinant protein yields can be generated from heterogeneous cell suspension cultures by flow sorting. Plant Biotechnol J (2012) 10:936-44. doi:10.1111/j.1467-7652.2012.00722.x
220. Khoudi H, Laberge S, Ferullo JM, Bazin R, Darveau A, Castonguay Y, et al. Production of a diagnostic monoclonal antibody in perennial alfalfa plants. Biotechnol Bioeng (1999) 64:135-43. doi:10.1002/(SICI)1097-0290(19990720)64:2<135::AID-BIT2>3.3.CO;2-H
221. Ma JK, Hikmat BY, WycoffK, Vine ND, Chargelegue D, Yu L, et al. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med (1998) 4:601-6. doi:10.1038/nm0598-601
222. Larrick JW, Yu L, Chen J, Jaiswal S, WycoffK. Production of antibodies in transgenic plants. Res Immunol (1998) 149:603-8. doi:10.1016/S0923-2494(98) 80013-8
223. WycoffKL. Secretory IgA antibodies from plants. Curr Pharm Des (2005) 11:2429-37. doi:10.2174/1381612054367508
224. McCormick AA. Tobacco derived cancer vaccines for non-Hodgkin's lymphoma: perspectives and progress. Hum Vaccin (2011) 7:305-12. doi:10.4161/hv.7.3.14163
225. HorneffG, Becker W, Wolf F, Kalden JR, Burmester GR. Human anti-murine immunoglobulin antibodies as disturbing factors in TSH determination. Klin Wochenschr (1991) 69:220-3. doi:10.1007/BF01646945
226. HorneffG, Winkler T, Kalden JR, Emmrich F, Burmester GR. Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritis. Clin Immunol Immunopathol (1991) 59:89-103. doi:10.1016/0090-1229(91)90084-N
227. Castilla J, Pintado B, Sola I, Sánchez-Morgado JM, Enjuanes L. Engineering passive immunity in transgenic mice secreting virus-neutralizing antibodies in milk. Nat Biotechnol (1998) 16:349-54. doi:10.1038/nbt0498-349
228. Castilla J, Sola I, Pintado B, Sánchez-Morgado JM, Enjuanes L. Lactogenic immunity in transgenic mice producing recombinant antibodies neutralizing coronavirus. Adv Exp Med Biol (1998) 440:675-86. doi:10.1007/978-1-4615-5331-1_87
229. Limonta J, Pedraza A, Rodríguez A, Freyre FM, Barral AM, Castro FO, et al. Production of active anti-CD6 mouse/human chimeric antibodies in the milk of transgenic mice. Immunotechnology (1995) 1:107-13. doi:10.1016/1380-2933(95)00010-0
230. Newton DL, Pollock D, DiTullio P, Echelard Y, Harvey M, Wilburn B, et al. Antitransferrin receptor antibody-RNase fusion protein expressed in the mammary gland of transgenic mice. J Immunol Methods (1999) 231:159-67. doi:10.1016/S0022-1759(99)00154-4
231. Gavin WG, Pollock D, Fell P, Yelton D, Cammuso C, Harrington M, et al. Expression of the antibody hBR96-2 in the milk of transgenic mice and production of hBR96-2 transgenic goats. Theriogenology (1997) 47:214. doi:10.1016/S0093-691X(97)82341-2
232. Zhu L, van de Lavoir M-C, Albanese J, Beenhouwer DO, Cardarelli PM, Cuison S, et al. Production of human monoclonal antibody in eggs of chimeric chickens. Nat Biotechnol (2005) 23:1159-69. doi:10.1038/nbt1132
233. Brüggemann M, Caskey HM, Teale C, Waldmann H, Williams GT, Surani MA, et al. A repertoire of monoclonal antibodies with human heavy chains from transgenic mice. Proc Natl Acad Sci U S A (1989) 86:6709-13. doi:10.1073/pnas.86.17.6709
234. Kuroiwa Y, Kasinathan P, Choi YJ, Naeem R, Tomizuka K, Sullivan EJ, et al. Cloned transchromosomic calves producing human immunoglobulin. Nat Biotechnol (2002) 20:889-94. doi:10.1038/nbt727
235. Kuroiwa Y, Kasinathan P, Matsushita H, Sathiyaselan J, Sullivan EJ, Kakitani M, et al. Sequential targeting of the genes encoding immunoglobulin-mu and prion protein in cattle. Nat Genet (2004) 36:775-80. doi:10.1038/ng1373
236. Richt JA, Kasinathan P, Hamir AN, Castilla J, Sathiyaseelan T, Vargas F, et al. Production of cattle lacking prion protein. Nat Biotechnol (2007) 25:132-8. doi:10.1038/nbt1271
237. Kuroiwa Y, Kasinathan P, Sathiyaseelan T, Jiao J, Matsushita H, Sathiyaseelan J, et al. Antigen-specific human polyclonal antibodies from hyperimmunized cattle. Nat Biotechnol (2009) 27:173-81. doi:10.1038/nbt.1521
238. Grosse-Hovest L, Müller S, Minoia R, Wolf E, Zakhartchenko V, Wenigerkind H, et al. Cloned transgenic farm animals produce a bispecific antibody for T cellmediated tumor cell killing. Proc Natl Acad Sci U S A (2004) 101:6858-63. doi:10.1073/pnas.0308487101
239. Flisikowska T, Thorey IS, Offner S, Ros F, Lifke V, Zeitler B, et al. Efficient immunoglobulin gene disruption and targeted replacement in rabbit using zinc finger nucleases. PLoS ONE (2011) 6:e21045. doi:10.1371/journal.pone.0021045
240. Mendicino M, Ramsoondar J, Phelps C, Vaught T, Ball S, LeRoith T, et al. Generation of antibody- and B cell-deficient pigs by targeted disruption of the Jregion gene segment of the heavy chain locus. Transgenic Res (2011) 20:625-41. doi:10.1007/s11248-010-9444-z
241. Ramsoondar J, Mendicino M, Phelps C, Vaught T, Ball S, Monahan J, et al. Targeted disruption of the porcine immunoglobulin kappa light chain locus. Transgenic Res (2011) 20:643-53. doi:10.1007/s11248-010-9445-y
242. Houdebine L-M. Production of pharmaceutical proteins by transgenic animals. Comp Immunol Microbiol Infect Dis (2009) 32:107-21. doi:10.1016/j.cimid.2007.11.005
243. Green LL, Hardy MC, Maynard-Currie CE, Tsuda H, Louie DM, Mendez MJ, et al. Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nat Genet (1994) 7:13-21. doi:10.1038/ng0594-13
244. Lonberg N, Huszar D. Human antibodies from transgenic mice. Int Rev Immunol (1995) 13:65-93. doi:10.3109/08830189509061738
245. Pruzina S, Williams GT, Kaneva G, Davies SL, Martín-López A, Brüggemann M, et al. Human monoclonal antibodies to HIV-1 gp140 from mice bearing YACbased human immunoglobulin transloci. Protein Eng Des Sel (2011) 24:791-9. doi:10.1093/protein/gzr038
246. Osborn MJ, Ma B, Avis S, Binnie A, Dilley J, Yang X, et al. High-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH/Igα/Igα loci bearing the rat CH region. J Immunol (2013) 190:1481-90. doi:10.4049/jimmunol.1203041
247. Chen C, Snedecor B, Nishihara JC, Joly JC, McFarland N, Andersen DC, et al. High-level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple-mutant (degP prc spr) host strain. Biotechnol Bioeng (2004) 85:463-74. doi:10.1002/bit.20014
248. Monsellier E, Bedouelle H. Improving the stability of an antibody variable fragment by a combination of knowledge-based approaches: validation and mechanisms. J Mol Biol (2006) 362:580-93. doi:10.1016/j.jmb.2006.07.044
249. Rahbarizadeh F, Rasaee MJ, Forouzandeh-Moghadam M, Allameh A-A. High expression and purification of the recombinant camelid anti-MUC1 single domain antibodies in Escherichia coli. Protein Expr Purif (2005) 44:32-8. doi:10.1016/j.pep.2005.04.008
250. Hussack G, Arbabi-Ghahroudi M, van Faassen H, Songer JG, Ng KK-S, MacKenzie R, et al. Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain. J Biol Chem (2011) 286:8961-76. doi:10.1074/jbc. M110.198754
251. Carter P, Kelley RF, Rodrigues ML, Snedecor B, Covarrubias M, Velligan MD, et al. High level Escherichia coli expression and production of a bivalent humanized antibody fragment. Biotechnology N Y (1992) 10:163-7.
252. Cossins AJ, Harrison S, Popplewell AG, Gore MG. Recombinant production of a VL single domain antibody in Escherichia coli and analysis of its interaction with peptostreptococcal protein L. Protein Expr Purif (2007) 51:253-9. doi:10.1016/j.pep.2006.07.013
253. Quintero-Hernández V, Juárez-González VR, Ortíz-León M, Sánchez R, Possani LD, Becerril B. The change of the scFv into the Fab format improves the stability and in vivo toxin neutralization capacity of recombinant antibodies. Mol Immunol (2007) 44:1307-15. doi:10.1016/j.molimm.2006.05.009
254. Yang T, Yang L, Chai W, Li R, Xie J, Niu B. A strategy for high-level expression of a single-chain variable fragment against TNFα by subcloning antibody variable regions from the phage display vector pCANTAB 5E into pBV220. Protein Expr Purif (2011) 76:109-14. doi:10.1016/j.pep.2010.10.006
255. King DJ, Byron OD, Mountain A, Weir N, Harvey A, Lawson AD, et al. Expression, purification and characterization of B72.3 Fv fragments. Biochem J (1993) 290(Pt 3):723-9.
256. Ye T, Lin Z, Lei H. High-level expression and characterization of an anti-VEGF165 single-chain variable fragment (scFv) by small ubiquitin-related modifier fusion in Escherichia coli. Appl Microbiol Biotechnol (2008) 81:311-7. doi:10.1007/s00253-008-1655-3
257. Nadkarni A, Kelley L-LC, Momany C. Optimization of a mouse recombinant antibody fragment for efficient production from Escherichia coli. Protein Expr Purif (2007) 52:219-29. doi:10.1016/j.pep.2006.10.011
258. Padiolleau-Lefevre S, Alexandrenne C, Dkhissi F, Clement G, Essono S, Blache C, et al. Expression and detection strategies for an scFv fragment retaining the same high affinity than Fab and whole antibody: implications for therapeutic use in prion diseases. Mol Immunol (2007) 44:1888-96. doi:10.1016/j.molimm.2006.09.035
259. Philibert P, Stoessel A, Wang W, Sibler A-P, Bec N, Larroque C, et al. A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm. BMC Biotechnol (2007) 7:81. doi:10.1186/1472-6750-7-81
260. Nesbeth DN, Perez-Pardo M-A, Ali S, Ward J, Keshavarz-Moore E. Growth and productivity impacts of periplasmic nuclease expression in an Escherichia coli Fab' fragment production strain. Biotechnol Bioeng (2012) 109:517-27. doi:10.1002/bit.23316
261. Ueda Y, Tsumoto K, Watanabe K, Kumagai I. Synthesis and expression of a DNA encoding the Fv domain of an anti-lysozyme monoclonal antibody, HyHEL10, in Streptomyces lividans. Gene (1993) 129:129-34. doi:10.1016/0378-1119(93)90708-B
262. Swennen D, Paul M-F, Vernis L, Beckerich J-M, Fournier A, Gaillardin C. Secretion of active anti-Ras single-chain Fv antibody by the yeasts Yarrowia lipolytica and Kluyveromyces lactis. Microbiology (2002) 148:41-50.
263. Rahbarizadeh F, Rasaee MJ, Forouzandeh M, Allameh A-A. Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris. Mol Immunol (2006) 43:426-35. doi:10.1016/j.molimm.2005.03.003
264. Ji X, Lu W, Zhou H, Han D, Yang L, Wu H, et al. Covalently dimerized Camelidae antihuman TNFa single-domain antibodies expressed in yeast Pichia pastoris show superior neutralizing activity. Appl Microbiol Biotechnol (2013). doi:10.1007/s00253-012-4639-2
265. Ezzine A, M'Hirsi el Adab S, Bouhaouala-Zahar B, Hmila I, Baciou L, Marzouki MN. Efficient expression of the anti-AahI' scorpion toxin nanobody under a new functional form in a Pichia pastoris system. Biotechnol Appl Biochem (2012) 59:15-21. doi:10.1002/bab.67
266. Maeng BH, Choi J, Sa YS, Shin JH, Kim YH. Functional expression of recombinant anti-BNP scFv in methylotrophic yeast Pichia pastoris and application as a recognition molecule in electrochemical sensors. World J Microbiol Biotechnol (2012) 28:1027-34. doi:10.1007/s11274-011-0901-5
267. Koliasnikov OV, Grigorenko VG, Egorov AM, Lange S, Schmid RD. Recombinant production of horseradish peroxidase conjugates with Fab antibodies in Pichia pastoris for analytical applications. Acta Naturae (2011) 3:85-92.
268. Schoonooghe S, Kaigorodov V, Zawisza M, Dumolyn C, Haustraete J, Grooten J, et al. Efficient production of human bivalent and trivalent anti-MUC1 Fab-scFv antibodies in Pichia pastoris. BMC Biotechnol (2009) 9:70. doi:10.1186/1472-6750-9-70
269. Gorlani A, de Haard H, Verrips T. Expression of VHHs in Saccharomyces cerevisiae. Methods Mol Biol (2012) 911:277-86. doi:10.1007/978-1-61779-968-6_17
270. Gorlani A, Hulsik DL, Adams H, Vriend G, Hermans P, Verrips T. Antibody engineering reveals the important role of J segments in the production efficiency of llama single-domain antibodies in Saccharomyces cerevisiae. Protein Eng Des Sel (2012) 25:39-46. doi:10.1093/protein/gzr057
271. Sommaruga S, Lombardi A, Salvadè A, Mazzucchelli S, Corsi F, GaleffiP, et al. Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells. Appl Microbiol Biotechnol (2011) 91:613-21. doi:10.1007/s00253-011-3306-3
272. Khatri NK, Gocke D, Trentmann O, Neubauer P, Hoffmann F. Single-chain antibody fragment production in Pichia pastoris: benefits of prolonged preinduction glycerol feeding. Biotechnol J (2011) 6:452-62. doi:10.1002/biot.201000193
273. Jafari R, Holm P, Piercecchi M, Sundström BE. Construction of divalent anti-keratin 8 single-chain antibodies (sc(Fv)2), expression in Pichia pastoris and their reactivity with multicellular tumor spheroids. J Immunol Methods (2011) 364:65-76. doi:10.1016/j.jim.2010.11.003
274. Barnard GC, Kull AR, Sharkey NS, Shaikh SS, Rittenhour AM, Burnina I, et al. High-throughput screening and selection of yeast cell lines expressing monoclonal antibodies. J Ind Microbiol Biotechnol (2010) 37:961-71. doi:10.1007/s10295-010-0746-1
275. Wang D, Su M, Sun Y, Huang S, Wang J, Yan W. Expression, purification and characterization of a human single-chain Fv antibody fragment fused with the Fc of an IgG1 targeting a rabies antigen in Pichia pastoris. Protein Expr Purif (2012) 86:75-81. doi:10.1016/j.pep.2012.08.015
276. Chen M-T, Lin S, Shandil I, Andrews D, Stadheim TA, Choi B-K. Generation of diploid Pichia pastoris strains by mating and their application for recombinant protein production. Microb Cell Fact (2012) 11:91. doi:10.1186/1475-2859-11-91
277. Sotiriadis A, Keshavarz T, Keshavarz-Moore E. Factors affecting the production of a single-chain antibody fragment by Aspergillus awamori in a stirred tank reactor. Biotechnol Prog (2001) 17:618-23. doi:10.1021/bp010026+
278. Gómez-Sebastián S, Nuñez MC, Garaicoechea L, Alvarado C, Mozgovoj M, Lasa R, et al. Rotavirus A-specific single-domain antibodies produced in baculovirusinfected insect larvae are protective in vivo. BMC Biotechnol (2012) 12:59. doi:10.1186/1472-6750-12-59
279. Kurasawa JH, Shestopal SA, Jha NK, Ovanesov MV, Lee TK, Sarafanov AG. Insect cell-based expression and characterization of a single-chain variable antibody fragment directed against blood coagulation factor VIII. Protein Expr Purif (2013) 88:201-6. doi:10.1016/j.pep.2012.12.008
280. Backovic M, Johansson DX, Klupp BG, Mettenleiter TC, Persson MAA, Rey FA. Efficient method for production of high yields of Fab fragments in Drosophila S2 cells. Protein Eng Des Sel (2010) 23:169-74. doi:10.1093/protein/gzp088
281. Johansson DX, Drakenberg K, Hopmann KH, Schmidt A, Yari F, Hinkula J, et al. Efficient expression of recombinant human monoclonal antibodies in Drosophila S2 cells. J Immunol Methods (2007) 318:37-46. doi:10.1016/j.jim.2006.08.017
282. Gilmartin AA, Lamp B, Rümenapf T, Persson MAA, Rey FA, Krey T. High-level secretion of recombinant monomeric murine and human single-chain Fv antibodies from Drosophila S2 cells. Protein Eng Des Sel (2012) 25:59-66. doi:10.1093/protein/gzr058
283. Palmberger D, Rendic D, Tauber P, Krammer F, Wilson IBH, Grabherr R. Insect cells for antibody production: evaluation of an efficient alternative. J Biotechnol (2011) 153:160-6. doi:10.1016/j.jbiotec.2011.02.009
284. Nettleship JE, Ren J, Rahman N, Berrow NS, Hatherley D, Neil Barclay A, et al. A pipeline for the production of antibody fragments for structural studies using transient expression in HEK 293T cells. Protein Expr Purif (2008) 62:83-9. doi:10.1016/j.pep.2008.06.017
285. Codamo J, Munro TP, Hughes BS, Song M, Gray PP. Enhanced CHO cell-based transient gene expression with the epi-CHO expression system. Mol Biotechnol (2011) 48:109-15. doi:10.1007/s12033-010-9351-9
286. Van Berkel PHC, Gerritsen J, van Voskuilen E, Perdok G, Vink T, van de Winkel JGJ, et al. Rapid production of recombinant human IgG with improved ADCC effector function in a transient expression system. Biotechnol Bioeng (2010) 105:350-7. doi:10.1002/bit.22535
287. Wulhfard S, Baldi L, Hacker DL, Wurm F. Valproic acid enhances recombinant mRNA and protein levels in transiently transfected Chinese hamster ovary cells. J Biotechnol (2010) 148:128-32. doi:10.1016/j.jbiotec.2010.05.003
288. Backliwal G, Hildinger M, Kuettel I, Delegrange F, Hacker DL, Wurm FM. Valproic acid: a viable alternative to sodium butyrate for enhancing protein expression in mammalian cell cultures. Biotechnol Bioeng (2008) 101:182-9. doi:10.1002/bit.21882
289. Wulhfard S, Tissot S, Bouchet S, Cevey J, de Jesus M, Hacker DL, et al. Mild hypothermia improves transient gene expression yields several fold in Chinese hamster ovary cells. Biotechnol Prog (2008) 24:458-65. doi:10.1021/bp070286c
290. Mader A, Prewein B, Zboray K, Casanova E, Kunert R. Exploration of BAC versus plasmid expression vectors in recombinant CHO cells. Appl Microbiol Biotechnol (2012) 97(9):4049-54. doi:10.1007/s00253-012-4498-x
291. Kober L, Zehe C, Bode J. Optimized signal peptides for the development of high expressing CHO cell lines. Biotechnol Bioeng (2013) 110:1164-73. doi:10.1002/bit.24776
292. Spens E, Häggström L. Defined protein and animal component-free NS0 fed-batch culture. Biotechnol Bioeng (2007) 98:1183-94. doi:10.1002/bit.21509
293. Burky JE, Wesson MC, Young A, Farnsworth S, Dionne B, Zhu Y, et al. Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies. Biotechnol Bioeng (2007) 96:281-93. doi:10.1002/bit.21060
294. Tchoudakova A, Hensel F, Murillo A, Eng B, Foley M, Smith L, et al. High level expression of functional human IgMs in human PER.C6 cells. MAbs (2009) 1:163-71. doi:10.4161/mabs.1.2.7945
295. Agrawal V, Slivac I, Perret S, Bisson L, St-Laurent G, Murad Y, et al. Stable expression of chimeric heavy chain antibodies in CHO cells. Methods Mol Biol (2012) 911:287-303. doi:10.1007/978-1-61779-968-6_18
296. Huang L, Li M-X, Lei Y, Wang Y-T, Xie K, Yang Y-L, et al. Expression, purification and activity determination of humanized anti-HER2 monoclonal antibody in CHO. Chin Pharm J (2012) 47:884-8.
297. Tran M, Van C, Barrera DJ, Pettersson PL, Peinado CD, Bui J, et al. Production of unique immunotoxin cancer therapeutics in algal chloroplasts. Proc Natl Acad Sci U S A (2013) 110:E15-22. doi:10.1073/pnas.1214638110
298. Almquist KC, McLean MD, Niu Y, Byrne G, Olea-Popelka FC, Murrant C, et al. Expression of an anti-botulinum toxin A neutralizing single-chain Fv recombinant antibody in transgenic tobacco. Vaccine (2006) 24:2079-86. doi:10.1016/j.vaccine.2005.11.014
299. Sainsbury F, Sack M, Stadlmann J, Quendler H, Fischer R, LomonossoffGP. Rapid transient production in plants by replicating and non-replicating vectors yields high quality functional anti-HIV antibody. PLoS ONE (2010) 5:e13976. doi:10.1371/journal.pone.0013976
300. Cui L, Peng H, Zhang R, Chen Y, Zhao L, Tang K. Recombinant hHscFv-RC-RNase protein derived from transgenic tobacco acts as a bifunctional molecular complex against hepatocellular carcinoma. Biotechnol Appl Biochem (2012) 59:323-9. doi:10.1002/bab.1039
301. Huang Z, Phoolcharoen W, Lai H, Piensook K, Cardineau G, Zeitlin L, et al. High-level rapid production of full-size monoclonal antibodies in plants by a singlevector DNA replicon system. Biotechnol Bioeng (2010) 106:9-17. doi:10.1002/bit.22652
302. Zhang R, Cui D, Wang H, Li C, Yao X, Zhao Y, et al. Functional recombinant human anti-HBV antibody expressed in milk of transgenic mice. Transgenic Res (2012) 21:1085-91. doi:10.1007/s11248-012-9589-z
303. Wei J, Yang X, Zheng M, Wang M, Dai Y, Chen Z, et al. The recombinant chimeric antibody chHAb18 against hepatocellular carcinoma can be produced in milk of transgenic mice. Transgenic Res (2011) 20:321-30. doi:10.1007/s11248-010-9408-3
304. Zhang R, Rao M, Li C, Cao J, Meng Q, Zheng M, et al. Functional recombinant human anti-HAV antibody expressed in milk of transgenic mice. Transgenic Res (2009) 18:445-53. doi:10.1007/s11248-008-9241-0
305. Yuskevich V, Khodarovich Y, Kagarliskiy G, Stremovskiy O, Maksimenko O, Lukash S, et al. Expression of humanized anti-Her2/neu single-chain IgG1-like antibody in mammary glands of transgenic mice. Biochimie (2011) 93:628-30. doi:10.1016/j.biochi.2010.12.001
306. Kamihira M, Kawabe Y, Shindo T, Ono K, Esaka K, Yamashita T, et al. Production of chimeric monoclonal antibodies by genetically manipulated chickens. J Biotechnol (2009) 141:18-25. doi:10.1016/j.jbiotec.2009.02.02